EP0907361A4 - Verfahren zur messung von muskoloaponeurotischen fibromatosen (desmoide tumoren) - Google Patents

Verfahren zur messung von muskoloaponeurotischen fibromatosen (desmoide tumoren)

Info

Publication number
EP0907361A4
EP0907361A4 EP97906588A EP97906588A EP0907361A4 EP 0907361 A4 EP0907361 A4 EP 0907361A4 EP 97906588 A EP97906588 A EP 97906588A EP 97906588 A EP97906588 A EP 97906588A EP 0907361 A4 EP0907361 A4 EP 0907361A4
Authority
EP
European Patent Office
Prior art keywords
methods
desmoid tumors
inhibiting
fibromatoses
musculoaponeurotic fibromatoses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97906588A
Other languages
English (en)
French (fr)
Other versions
EP0907361A1 (de
Inventor
Maria L Brandi
Francesco Tonelli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603148.9A external-priority patent/GB9603148D0/en
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of EP0907361A1 publication Critical patent/EP0907361A1/de
Publication of EP0907361A4 publication Critical patent/EP0907361A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
EP97906588A 1996-01-29 1997-01-27 Verfahren zur messung von muskoloaponeurotischen fibromatosen (desmoide tumoren) Withdrawn EP0907361A4 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US1077396P 1996-01-29 1996-01-29
US10773P 1996-01-29
GB9603148 1996-02-15
GBGB9603148.9A GB9603148D0 (en) 1996-02-15 1996-02-15 Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors)
PCT/US1997/002287 WO1997026878A1 (en) 1996-01-29 1997-01-27 Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors)

Publications (2)

Publication Number Publication Date
EP0907361A1 EP0907361A1 (de) 1999-04-14
EP0907361A4 true EP0907361A4 (de) 2002-05-02

Family

ID=26308707

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97906588A Withdrawn EP0907361A4 (de) 1996-01-29 1997-01-27 Verfahren zur messung von muskoloaponeurotischen fibromatosen (desmoide tumoren)

Country Status (11)

Country Link
EP (1) EP0907361A4 (de)
JP (1) JP2000503995A (de)
KR (1) KR19990082055A (de)
CN (1) CN1209746A (de)
AU (1) AU707675B2 (de)
CZ (1) CZ235398A3 (de)
EA (1) EA199800678A1 (de)
IL (1) IL125523A0 (de)
NO (1) NO983452D0 (de)
PL (1) PL328127A1 (de)
WO (1) WO1997026878A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2135195C1 (ru) * 1998-12-17 1999-08-27 Овсюк Валерий Григорьевич Способ получения материала, содержащего клетки предстательной железы, материал, содержащий клетки предстательной железы, и способы лечения фиброматоза матки, хронического простатита и нарушений мужской половой функции методом трансплантации
AU781168B2 (en) 2001-01-26 2005-05-12 Pfizer Products Inc. Method of treating certain cancers using an estrogen agonist/antagonist

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994017839A1 (en) * 1993-02-09 1994-08-18 Arch Development Corporation Method for the improvement of scar size and appearance
EP0652004A1 (de) * 1993-10-15 1995-05-10 Eli Lilly And Company Methode zur Behandlung von resistenten Neoplasmen
EP0664122A1 (de) * 1993-12-21 1995-07-26 Eli Lilly And Company Hemmung unvollständiger Gewebeheilung
US5457116A (en) * 1993-10-15 1995-10-10 Eli Lilly And Company Methods of inhibiting uterine fibrosis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994017839A1 (en) * 1993-02-09 1994-08-18 Arch Development Corporation Method for the improvement of scar size and appearance
EP0652004A1 (de) * 1993-10-15 1995-05-10 Eli Lilly And Company Methode zur Behandlung von resistenten Neoplasmen
US5457116A (en) * 1993-10-15 1995-10-10 Eli Lilly And Company Methods of inhibiting uterine fibrosis
EP0664122A1 (de) * 1993-12-21 1995-07-26 Eli Lilly And Company Hemmung unvollständiger Gewebeheilung

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9726878A1 *

Also Published As

Publication number Publication date
AU707675B2 (en) 1999-07-15
PL328127A1 (en) 1999-01-18
KR19990082055A (ko) 1999-11-15
NO983452L (no) 1998-07-27
JP2000503995A (ja) 2000-04-04
EA199800678A1 (ru) 1999-02-25
CZ235398A3 (cs) 1999-02-17
IL125523A0 (en) 1999-03-12
EP0907361A1 (de) 1999-04-14
CN1209746A (zh) 1999-03-03
WO1997026878A1 (en) 1997-07-31
NO983452D0 (no) 1998-07-27
AU2124097A (en) 1997-08-20

Similar Documents

Publication Publication Date Title
ZA977087B (en) Methods of cancer treatment using naaladase inhibitors
HUP9700602A3 (en) New inhibitors of bone-resorption and vitronectine-receptor-antagonists
ZA977085B (en) Naaladase inhibitors
PL331900A1 (en) 1,4-heterocyclic inhibitors of metaloprotease
PL331838A1 (en) 1,3-diheterocyclic inhibitors of metaloproteases
PL327569A1 (en) Promedications of thrombosin inhibitors
PL331338A1 (en) Thiosulphonamidic metaloprotease inhibitors
PL328831A1 (en) Combined treatment of osteoporosis
PL331920A1 (en) Spirocyclic inhibitors of metaloproteases
IL112043A0 (en) Methods of inhibiting emperfect tissue repair
PL331803A1 (en) Bidonoric metaloprotease inhibitors
IL127605A0 (en) Methods of cancer treatment using naaladase inhibitors
EP1017459A4 (de) Glücksspiel
GB9621570D0 (en) Formulations and methods for inhibiting bone loss
PL331766A1 (en) Method of inhibiting fas expression
ZA9711238B (en) Preparation of N-substituted 3-hydroxypyrozoles
ZA9710989B (en) Polyprolyl inhibitors of cyclophilin
CY2590B2 (en) Preparation of 1-butyl-4-piperidinylmethylamine
IL125523A0 (en) Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors)
HU9702479D0 (en) New polymorphe modification of doxazosin-mesylate
GB9603148D0 (en) Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors)
IL115383A0 (en) Methods of inhibiting endometrial mitoses
GB9617346D0 (en) Therapeutic methods and compositions for use therein
HUP9901961A3 (en) Use of benzotiophene derivatives for producing pharmaceuticals inhibiting musculoaponeurotic fibromatoses (desmoid tumors)
PL105402U1 (en) Hardware of line stand-isolator

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19980727

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

AX Request for extension of the european patent

Free format text: AL PAYMENT 980727;LV PAYMENT 980727;RO PAYMENT 980727;SI PAYMENT 980727

A4 Supplementary search report drawn up and despatched

Effective date: 20020318

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20020605